Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study
- Resource Type
- Article
- Authors
- Kosiborod, Mikhail; Cavender, Matthew A.; Fu, Alex Z.; Wilding, John P.; Khunti, Kamlesh; Norhammar, Anna; Birkeland, Kåre; Jørgensen, Marit Eika; Holl, Reinhard W.; Lam, Carolyn SP; Gulseth, Hanne Løvdal; Carstensen, Bendix; Bollow, Esther; Franch-Nadal, Josep; García Rodríguez, Luis Alberto; Karasik, Avraham; Tangri, Navdeep; Kohsaka, Shun; Kim, Dae Jung; Shaw, Jonathan; Arnold, Suzanne; Goh, Su-Yen; Hammar, Niklas; Fenici, Peter; Bodegård, Johan; Chen, Hungta; Surmont, Filip; Nahrebne, Kyle; Blak, Betina T.; Wittbrodt, Eric T.; Saathoff, Matthias; Noguchi, Yusuke; Tan, Donna; Williams, Maro; Lee, Hye Won; Greenbloom, Maya; Kaidanovich-Beilin, Oksana; Yeo, Khung Keong; Bee, Yong Mong; Khoo, Joan; Koong, Agnes; Lau, Yee How; Gao, Fei; Tan, Wee Boon; Kadir, Hanis Abdul; Ha, Kyoung Hwa; Lee, Jinhee; Chodick, Gabriel; Melzer Cohen, Cheli; Whitlock, Reid; Cea Soriano, Lucia; Fernándex Cantero, Oscar; Riehle, Ellen; Ilomaki, Jennie; Magliano, Dianna; Lam, Carolyn S.P.; Thuresson, Marcus
- Source
- In Journal of the American College of Cardiology 12 June 2018 71(23):2628-2639
- Subject
- Language
- ISSN
- 0735-1097